Adicet Bio, Inc.ACETNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-6.34%
↓ 113% below average
Average (9y)
50.54%
Historical baseline
Range
High:183.39%
Low:-12.60%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -6.34% |
| 2023 | 48.84% |
| 2022 | 45.57% |
| 2021 | 42.55% |
| 2020 | 44.92% |
| 2019 | 60.98% |
| 2018 | -12.60% |
| 2017 | 183.39% |
| 2016 | 13.79% |
| 2015 | 84.26% |